Inventor
Lianshan Zhang
Inventor
Shanghai, CN
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes28%
C07KPeptides26%
C12NMicroorganisms or enzymes7%
C07DHeterocyclic compounds4%
G06FElectric digital data processing1%
G09GArrangements or circuits for control of indicating devices using static means to present variable information1%
G10LSpeech analysis techniques or speech synthesis1%
H04NPictorial communication, e.g. television1%
PatentTitleYear
10,972,802Methods and systems for implementing an elastic cloud based voice search using a third-party search provider202110,857,146Method for preventing or treating tumor diseases with a combination of tyrosine kinase inhibitor and CDK4/6 inhibitor202010,815,304PD-L1 antibody, antigen-binding fragment thereof and medical application thereof202010,793,643PCSK9 antibody, antigen-binding fragment thereof, and medical application thereof202010,786,567Stable anti-PD-1 antibody pharmaceutical preparation and application thereof in medicine202010,562,977Ligand-cytotoxic drug conjugate, preparation method thereof, and uses thereof202010,543,284Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereof202010,449,250Anti-sclerostin antibody, antigen binding fragment and medical use thereof201910,344,090PD-1 antibody, antigen-binding fragment thereof, and medical application thereof201910,206,980IL-15 heterodimeric protein and uses thereof20199,862,765'IL-17A binding agent and uses thereof'20189,458,219'Human insulin analogue and acylated derivative thereof'20169,145,451'Glucagon superfamily peptides exhbiting G protein coupled receptor activity'20159,090,568'Quinazolinediones and their use'20159,050,371'PEGylated insulin lispro compounds'20158,183,340'GLP-1 pegylated compounds'20127,897,573'Selective VPAC2 receptor peptide agonists'20117,582,608'Selective VPAC2 receptor peptide agonists'20097,557,183'Polyethylene glycol linked GLP-1 compounds'20097,482,321'Extended glucagon-like peptide-1 analogs'20097,101,843'Glucagon-like peptide-1 analogs'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2015Patents assigned to LILLY CO ELI (7)· patent assignee history
2006–2015Based in Carmel, IN, US· patent location history
2012–2015Patents assigned to ZHANG LIANSHAN (4)· patent assignee history
2016–2020Patents assigned to JIANGSU HENGRUI MEDICINE CO (11)· patent assignee history
2016–2020Patents assigned to Shanghai hengrui pharmaceutical co ltd (11)· patent assignee history
2016–2019Based in Lianyungang, CN· patent location history
2018–2020Based in Shanghai, CN· patent location history
2020Patents assigned to SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD (3)· patent assignee history
2020Based in Jiangsu, CN· patent location history
2021Based in Pittsburgh, PA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JIANGSU HENGRUI MEDICINE CO | 11 | 2016–2020 |
| Shanghai hengrui pharmaceutical co ltd | 11 | 2016–2020 |
| LILLY CO ELI | 7 | 2006–2015 |
| ZHANG LIANSHANself | 4 | 2012–2015 |
| SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD | 3 | 2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Shanghai, CN | 8 | 2018–2020 |
| Carmel, IN, US | 7 | 2006–2015 |
| Lianyungang, CN | 2 | 2016–2019 |
| Pittsburgh, Pennsylvania, US | 1 | 2021 |
| Jiangsu, CN | 1 | 2020 |